Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acceleron Pharma Inc (NASDAQ:XLRN)

30.21
Delayed Data
As of Aug 26
 +0.56 / +1.89%
Today’s Change
21.93
Today|||52-Week Range
50.86
-38.04%
Year-to-Date
No recent news for Acceleron Pharma Inc.

Today’s Trading

Previous close29.65
Today’s open29.78
Day’s range29.40 - 30.55
Volume148,323
Average volume (3 months)321,340
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-17.71%
Earnings growth (this year)+16.00%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+23.68%
P/E ratioNM
Price/Sales89.73
Price/Book9.21

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.93+2.13%
HALOHalozyme Therapeutic...+0.27+2.83%
CHRSCoherus BioSciences ...+0.04+0.14%
MNTAMomenta Pharmaceutic...-0.51-4.01%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$18.1M
Annual profit (last year)-$63.9M
Net profit margin-353.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Knopf
Chief Operating Officer &
Executive Vice President
Steven D. Ertel
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs